0001209191-20-059255.txt : 20201118 0001209191-20-059255.hdr.sgml : 20201118 20201118193043 ACCESSION NUMBER: 0001209191-20-059255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Renaud Ronald C JR CENTRAL INDEX KEY: 0001354434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38550 FILM NUMBER: 201326657 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Translate Bio, Inc. CENTRAL INDEX KEY: 0001693415 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 611807780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-945-7361 MAIL ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: RaNA Therapeutics, Inc. DATE OF NAME CHANGE: 20161228 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001693415 Translate Bio, Inc. TBIO 0001354434 Renaud Ronald C JR C/O TRANSLATE BIO, INC. 29 HARTWELL AVE LEXINGTON MA 02421 1 1 0 0 Chief Executive Officer, Pres. Common Stock 2020-11-16 4 M 0 53004 7.39 A 488563 D Common Stock 2020-11-16 4 M 0 3 8.34 A 488566 D Common Stock 409913 I By Ronald Renaud 2014 Irrevocable Family Trust Common Stock 40909 I By Ronald C. Renaud, Jr. Trust - 2007 Stock Option (right to buy) 7.39 2020-11-16 4 M 0 53004 0.00 D 2027-12-21 Common Stock 53004 1085673 D Stock Option (right to buy) 8.34 2020-11-16 4 M 0 3 0.00 D 2028-03-06 Common Stock 3 89997 D This option was granted on December 22, 2017. The shares underlying the option are scheduled to vest over four years in equal monthly installments through March 9, 2021. This option was granted on March 7, 2018. 25% of the shares vested on March 7, 2019 and the remainder are scheduled to vest in equal monthly installment through March 7, 2022. /s/ Paul Burgess, as attorney-in-fact for Ronald C. Renaud, Jr. 2020-11-17